TLR4 in glioblastoma—when cancer stem cells ignore “danger signals”

par Beier, Christoph P., Kristensen, Bjarne W.
Publié dans Stem Cell Investig (2017)

Cardiac leiomyosarcoma, a case report

par Andersen, Rikke E, Kristensen, Bjarne W, Gill, Sabine
Publié 2013

Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS)

par Woehrer, Adelheid, Kristensen, Bjarne W., Vital, Anne, Hainfellner, Johannes A.
Publié dans Clin Neuropathol (2017)

Inconsistent Immunohistochemical Expression Patterns of Four Different CD133 Antibody Clones in Glioblastoma

par Hermansen, Simon K., Christensen, Karina G., Jensen, Stine S., Kristensen, Bjarne W.
Publié 2011

A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1

par Dahlrot, Rikke H, Kristensen, Bjarne W, Hjelmborg, Jacob, Herrstedt, Jørn, Hansen, Steinbjørn
Publié 2012

Hormonal contraceptive use and risk of glioma among younger women: a nationwide case–control study

par Andersen, Lene, Friis, Søren, Hallas, Jesper, Ravn, Pernille, Kristensen, Bjarne W, Gaist, David
Publié dans Br J Clin Pharmacol (2015)

Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo

par Jensen, Stine S., Petterson, Stine A., Halle, Bo, Aaberg-Jessen, Charlotte, Kristensen, Bjarne W.
Publié dans BMC Cancer (2017)

Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures

par Aaberg-Jessen, Charlotte, Nørregaard, Annette, Christensen, Karina, Pedersen, Christian B, Andersen, Claus, Kristensen, Bjarne W
Publié 2013

Clinical value of CD133 and nestin in patients with glioma: a population-based study

par Dahlrot, Rikke H, Hansen, Steinbjørn, Jensen, Stine S, Schrøder, Henrik D, Hjelmborg, Jacob, Kristensen, Bjarne W
Publié 2014

Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas

par Ramachandran, Rahimsan K., Sørensen, Mia D., Aaberg-Jessen, Charlotte, Hermansen, Simon K., Kristensen, Bjarne W.
Publié dans PLoS One (2017)

SuperQuant-assisted comparative proteome analysis of glioblastoma subpopulations allows for identification of potential novel therapeutic targets and cell markers

par Verano-Braga, Thiago, Gorshkov, Vladimir, Munthe, Sune, Sørensen, Mia D., Kristensen, Bjarne W., Kjeldsen, Frank
Publié dans Oncotarget (2018)

The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas

par Meta, Rahmina, Boldt, Henning B., Kristensen, Bjarne W., Sahm, Felix, Sjursen, Wenche, Torp, Sverre H.
Publié dans Cancers (Basel) (2021)

D-2-hydroxyglutarate is an intercellular mediator in IDH-mutant gliomas inhibiting complement and T cells

par Zhang, Lingjun, Sorensen, Mia D., Kristensen, Bjarne W., Reifenberger, Guido, McIntyre, Thomas M., Lin, Feng
Publié dans Clin Cancer Res (2018)

A 4-miRNA signature to predict survival in glioblastomas

par Hermansen, Simon K., Sørensen, Mia D., Hansen, Anker, Knudsen, Steen, Alvarado, Alvaro G., Lathia, Justin D., Kristensen, Bjarne W.
Publié dans PLoS One (2017)

PATH-52. TIME-VARYING EFFECT OF MGMT METHYLATION LEVEL ON SURVIVAL OF GLIOBLASTOMA MULTIFORME

par Dahlrot, Rikke H, Larsen, Pia V, Boldt, Henning, Kreutzfeldt, Melissa S, Hjelmborg, Jacob v B, Hansen, Steinbjørn, Kristensen, Bjarne W
Publié dans Neuro Oncol (2017)

Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

par Aaberg-Jessen, Charlotte, Halle, Bo, Jensen, Stine S., Müller, Sven, Rømer, Unni Maria, Pedersen, Christian B., Brünner, Nils, Kristensen, Bjarne W.
Publié dans J Neurooncol (2016)

Expression and prognostic value of JAM-A in gliomas

par Rosager, Ann Mari, Sørensen, Mia D., Dahlrot, Rikke H., Boldt, Henning B., Hansen, Steinbjørn, Lathia, Justin D., Kristensen, Bjarne W.
Publié dans J Neurooncol (2017)

Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas

par Aaberg-Jessen, Charlotte, Sørensen, Mia D., Matos, Ana L. S. A., Moreira, José M., Brünner, Nils, Knudsen, Arnon, Kristensen, Bjarne W.
Publié dans BMC Cancer (2018)

APNG as a prognostic marker in patients with glioblastoma

par Fosmark, Sigurd, Hellwege, Sofie, Dahlrot, Rikke H., Jensen, Kristian L., Derand, Helene, Lohse, Jesper, Sørensen, Mia D., Hansen, Steinbjørn, Kristensen, Bjarne W.
Publié dans PLoS One (2017)

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification

par Nielsen, Ljudmilla A. G., Bangsø, Julie A., Lindahl, Kim H., Dahlrot, Rikke H., Hjelmborg, Jacob v. B., Hansen, Steinbjørn, Kristensen, Bjarne W.
Publié dans Diagn Pathol (2018)